Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the Centers for Medicare & Medicaid ...
ECRI included other medtech-related threats on its list of patient safety concerns, noting that cybersecurity breaches can ...
Reports Q4 revenue $2M vs. $1.8M last year. Dr. Deepika Vuppalanchi, Chair and CEO of Syra Health (SYRA), said, “Since our IPO and listing on ...
As of late February, there were 147 medical device recall events and 20 of them, or 13.6%, were Class I, according to a Modern Healthcare report.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback